Your cart is currently empty!
NAMSA sits down with Adrian Keene, Vice President of Global Biological Safety/Validation and EMEA Consulting Services, to discuss the EU Parliament’s approval of the transitional provision extension of the EU MDR and IVDR. Provided is information on how the amendment, passed on 16 February 2023, outlines new compliance dates for legacy device and removes the sell-off period for both medical and IVD products.
Schedule a Consultation with NAMSA’s regulatory experts.
*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed by NAMSA to better understand your product needs and interests. At any time, you can submit a request to withdraw your consent for the use of information provided by you by contacting us at: communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com.
NAMSA uses a third-party provider, GoToWebinar, to host NAMSA webinars. For information related to GoToWebinar’s privacy policy and utilization of information, please contact GoToWebinar directly.